Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies

被引:19
|
作者
Su, Jin-xuan [1 ,2 ]
Li, Si-jia [1 ,2 ]
Zhou, Xiao-feng [1 ,2 ]
Zhang, Zhi-jing [1 ,2 ]
Yan, Yu [3 ]
Liu, Song-lin [4 ]
Qi, Qi [1 ,2 ]
机构
[1] Jinan Univ, Sch Med, Dept Pharmacol, State Key Lab Bioact Mol & Druggabil Assessment, Guangzhou 510632, Peoples R China
[2] Jinan Univ, Sch Med, Dept Pharmacol, MOE Key Lab Tumor Mol Biol, Guangzhou 510632, Peoples R China
[3] Jinan Univ, Funct Expt Teaching Ctr, Sch Med, Guangzhou 510632, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Peoples R China
基金
中国国家自然科学基金;
关键词
anti-cancer drugs; chemotherapy; metastasis; combination therapy; BREAST-CANCER CELLS; FACTOR-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; LUNG-CANCER; TGF-BETA; PANCREATIC-CANCER; TUMOR-CELLS; TAMOXIFEN RESISTANCE; LIVER METASTASIS; DOUBLE-BLIND;
D O I
10.1038/s41401-023-01093-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chemotherapy, the most widely accepted treatment for malignant tumors, is dependent on cell death induced by various drugs including antimetabolites, alkylating agents, mitotic spindle inhibitors, antitumor antibiotics, and hormonal anticancer drugs. In addition to causing side effects due to non-selective cytotoxicity, chemotherapeutic drugs can initiate and promote metastasis, which greatly reduces their clinical efficacy. The knowledge of how they induce metastasis is essential for developing strategies that improve the outcomes of chemotherapy. Herein, we summarize the recent findings on chemotherapy-induced metastasis and discuss the underlying mechanisms including tumor-initiating cell expansion, the epithelial-mesenchymal transition, extracellular vesicle involvement, and tumor microenvironment alterations. In addition, the use of combination treatments to overcome chemotherapy-induced metastasis is also elaborated.
引用
收藏
页码:1725 / 1736
页数:12
相关论文
共 50 条
  • [41] Chemotherapy-Induced Molecular Changes in Skeletal Muscle
    Pedrosa, Mafalda Barbosa
    Barbosa, Samuel
    Vitorino, Rui
    Ferreira, Rita
    Moreira-Goncalves, Daniel
    Santos, Lucio Lara
    BIOMEDICINES, 2023, 11 (03)
  • [43] Chemotherapy-induced myelotoxicity and incidence of lung metastasis in an animal model
    Son, Jin-Young
    Shin, Jang-Woo
    Wang, Jing-Hua
    Park, Hye-Jung
    Kim, Hyeong-Geug
    Raghavendran, Hanumantha Rao Balaji
    Son, Chang-Gue
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2011, 30 (07) : 649 - 655
  • [44] MECHANISMS AND PREVENTION FOR CANCER CHEMOTHERAPY-INDUCED BONE DEFECTS
    Xian, C.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S508 - S508
  • [45] MECHANISMS OF AXON DEGENERATION IN CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
    Diantonio, Aaron
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2025, 30 (01)
  • [46] Clinical course and treatment of chemotherapy-induced emesis
    duBois, A
    MEDIZINISCHE KLINIK, 1995, 90 : 1 - 4
  • [47] Chemotherapy-Induced Cardiomyopathy: Clinical Scenarios and Challenges
    Gupta, Dipti
    Chan, Angel
    Jordan, Jonathan
    Steingart, Richard M.
    ONCOLOGY-NEW YORK, 2015, 29 (10): : 730 - +
  • [48] Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues
    Bae, Esther H.
    Greenwald, Mark K.
    Schwartz, Ann G.
    NEUROTHERAPEUTICS, 2021, 18 (04) : 2384 - 2396
  • [49] Potential mechanisms for chemotherapy-induced impairments in cognitive function
    Jansen, C
    Miaskowski, C
    Dodd, M
    Dowling, G
    Kramer, J
    ONCOLOGY NURSING FORUM, 2005, 32 (06) : 1151 - 1161
  • [50] CHEMOTHERAPY-INDUCED PREMATURE OVARIAN FAILURE - MECHANISMS AND PREVENTION
    ATAYA, K
    MOGHISSI, K
    STEROIDS, 1989, 54 (06) : 607 - 626